About TELLBIO, INC.
TellBio is a development-stage biotechnology company focused on revolutionizing cancer detection and treatment through its proprietary circulating tumor cell (CTC) technology platform, the TellDx CTC System. The company's approach is based on decades of academic and clinical research, exclusively licensed from Massachusetts General Hospital.
Diagnostics platform that isolates circulating tumor cells (CTCs)Therapeutics platform that generates novel anti-cancer drugs using CTC-derived knowledgeMicrofluidic diagnostic tool for detecting and monitoring cancer progression
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to TELLBIO, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.